Clinical trial
Observational Study to Evaluate Risks of Side Effects, Drug Abuse and Dependence…
NCT00244465 · UCB Pharma, Industry · Completed
Key facts
| NCT number | NCT00244465 |
|---|---|
| Title | Observational Study to Evaluate Risks of Side Effects, Drug Abuse and Dependence in Patients Who Received Xyrem ® on Prescription |
| Official title | Post Marketing Non-interventional Surveillance Pharmacoepidemiology Study (PMSS) to Evaluate Long-term Safety, Tolerability and Compliance in Administration of Xyrem® (Sodium Oxybate) Oral Solution in Patients Who Receive Treatment With This Medication in Regular Clinical Practice. |
| Lead sponsor | UCB Pharma, Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | Narcolepsy |
| Enrollment | 750 |
| Start date | May 1, 2006 |
| Primary completion | Sep 1, 2016 |
| Completion | Sep 1, 2016 |
| First posted | Oct 26, 2005 |
| Last update posted | Sep 7, 2016 |
| Countries | Austria, Belgium, Czechia, Germany, Ireland, Italy, Spain, Switzerland, United Kingdom |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: